Down-regulation of the expression of CCAAT/enhancer binding protein α gene in cervical squamous cell carcinoma

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Pan, Zemin ^a,b   Zheng, Weinan ^a,b   Zhang, Jinli ^a,b   Gao, Rui ^a,b   Li, Dongmei ^a   Guo, Xiaoqing ^a   Han, Hu ^a   Li, Feng ^a   Qu, Shen ^b   Shao, Renfu ^c  

^a SHIHEZI UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c UNIVERSITY OF THE SUNSHINE COAST   (Australia)

Author keywords

C EBP gene; Cervical squamous cell carcinoma; Gene expression

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; MESSENGER RNA;

ARTICLE; CCAAT ENHANCER BINDING PROTEIN ALPHA GENE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HELA CELL LINE; HUMAN; HUMAN TISSUE; PROMOTER REGION; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE; UTERINE CERVICITIS; UTERINE CERVIX CARCINOMA; CANCER GRADING; CELL MOTION; CELL SURVIVAL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; PATHOLOGY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

CARCINOMA, SQUAMOUS CELL; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL MOVEMENT; CELL SURVIVAL; DNA METHYLATION; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM GRADING; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; TRANSFECTION; UTERINE CERVICAL NEOPLASMS;

EID: 84903265648     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-417     Document Type: Article

References (25)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012, 62(1):10-29. 10.3322/caac.20138, 22237781.
2. Pan Z, Li J, Pan X, Chen S, Wang Z, Li F, Qu S, Shao R. Methylation of the RASSF1A gene promoter in Uigur women with cervical squamous cell carcinoma. Tumori 2009, 95(1):76-80.
3. Rishi V, Bhattacharya P, Chatterjee R, Rozenberg J, Zhao J, Glass K, Fitzgerald P, Vinson C. CpG methylation of half-CRE sequences creates C/EBPα binding sites that activate some issue-specific genes. Proc Natl Acad Sci U S A 2010, 107(47):20311-20316. 10.1073/pnas.1008688107, 2996703, 21059933.
4. Shim M, Powers KL, Ewing SJ, Zhu S, Smart RC. Diminished expression of C/EBPalpha in skin carcinomas is linked to oncogenic Ras and reexpression of C/EBPalpha in carcinoma cells inhibits proliferation. Cancer Res 2005, 65(3):861-867.
5. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA. C/EBPa arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 2001, 8(4):817-828. 10.1016/S1097-2765(01)00366-5, 11684017.
6. Satoh T, Kidoya H, Naito H, Yamamoto M, Takemura N, Nakagawa K, Yoshioka Y, Morii E, Takakura N, Takeuchi O, Akira S. Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 2013, 495(7442):524-528. 10.1038/nature11930, 23515163.
7. Di Tullio A, Graf T. C/EBPα bypasses cell cycle-dependency during immune cell transdifferentiation. Cell Cycle 2012, 11(14):2739-2746. 10.4161/cc.21119, 22771961.
8. Loomis KD, Zhu S, Yoon K, Johnson PF, Smart RC. Genetic ablation of CCAAT/enhancer binding protein alpha in epidermis reveals its role in suppression of epithelial tumorigenesis. Cancer Res 2007, 67(14):6768-6776. 10.1158/0008-5472.CAN-07-0139, 3773581, 17638888.
9. Sato A, Yamada N, Ogawa Y, Ikegami M. CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway. PLoS One 2013, 8(2):e57013. 10.1371/journal.pone.0057013, 3577786, 23437297.
10. Pan Z, Chen S, Pan X, Wang Z, Han H, Zheng W, Wang X, Li F, Qu S, Shao R. Differential gene expression identified in Uigur women cervical squamous cell carcinoma by suppression subtractive hybridization. Neoplasma 2010, 57(2):123-128. 10.4149/neo_2010_02_123, 20099975.
11. Ko CY, Hsu HC, Shen MR, Chang WC, Wang JM. Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex. J Biol Chem 2008, 283(45):30919-30932. 10.1074/jbc.M804029200, 2662167, 18753137.
12. Schatz P, Dietrich D, Schuster M. Rapid analysis of CpG methylation patterns using RNase T1 cleavage and MALDI-TOF. Nucleic Acids Res 2004, 32(21):e167. 10.1093/nar/gnh165, 535694, 15576674.
13. Kumagai T, Akagi T, Desmond JC, Kawamata N, Gery S, Imai Y, Song JH, Gui D, Said J, Koeffler HP. Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells. Int J Cancer 2009, 124(4):827-833. 10.1002/ijc.23994, 3471542, 19035457.
14. Regalo G, Resende C, Wen X, Gomes B, Durães C, Seruca R, Carneiro F, Machado JC. C/EBP alpha expression is associated with homeostasis of the gastric epithelium and with gastric carcinogenesis. Lab Invest 2010, 90(8):1132-1139. 10.1038/labinvest.2010.79, 20386538.
15. Taylor BS, DeCarolis PL, Angeles CV, Brenet F, Schultz N, Antonescu CR, Scandura JM, Sander C, Viale AJ, Socci ND, Singer S. Frequent alterations and epigenetic silencing of differentiation pathway genes in structurally rearranged liposarcomas. Cancer Discov 2011, 1(7):587-597. 10.1158/2159-8290.CD-11-0181, 3274776, 22328974.
16. Crago AM, Socci ND, DeCarolis P, O'Connor R, Taylor BS, Qin LX, Antonescu CR, Singer S. Copy number losses define subgroups of dedifferentiated liposarcoma with poor prognosis and genomic instability. Clin Cancer Res 2012, 18(5):1334-1340. 10.1158/1078-0432.CCR-11-2820, 3294014, 22241790.
17. Zhang S, Jiang T, Feng L, Sun J, Lu H, Wang Q, Pan M, Huang D, Wang X, Wang L, Jin H. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer binding protein alpha. J Mol Med (Berl) 2012, 90(9):1069-1077. 10.1007/s00109-012-0879-y, 22391813.
18. Eyholzer M, Schmid S, Wilkens L, Mueller BU, Pabst T. The tumour-uppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. Br J Cancer 2010, 103(2):275-284. 10.1038/sj.bjc.6605751, 2906742, 20628397.
19. Zhang C, Chi YL, Wang PY, Wang YQ, Zhang YX, Deng J, Lv CJ, Xie SY. miR-511 and miR-1297 inhibit human lung adenocarcinoma cell proliferation by targeting oncogene TRIB2. PLoS One 2012, 7(10):e46090. 10.1371/journal.pone.0046090, 3465292, 23071539.
20. Patrick BA, Jaiswal AK. Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancer. Oncogene 2012, 31(40):4362-4371. 10.1038/onc.2011.600, 3538879, 22249251.
21. Bereshchenko O, Mancini E, Moore S, Bilbao D, Månsson R, Luc S, Grover A, Jacobsen SE, Bryder D, Nerlov C. Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. Cancer Cell 2009, 16(5):390-400. 10.1016/j.ccr.2009.09.036, 19878871.
22. Pabst T, Mueller BU. Complexity of CEBPA dysregulation in human acute myeloid leukemia. Clin Cancer Res 2009, 15(17):5303-5307. 10.1158/1078-0432.CCR-08-2941, 19706798.
23. Chang KW, Hung PS, Lin IY, Hou CP, Chen LK, Tsai YM, Lin SC. Curcumin upregulates insulin-like growth factor binding protein-5 (IGFBP-5) and C/EBPalpha during oral cancer suppression. Int J Cancer 2010, 127(1):9-20. 10.1002/ijc.25220, 20127863.
24. Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A, Zhang P, Santana-Lemos BA, Neuberg D, Wagers AJ, Rego EM, Tenen DG. Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood 2009, 114(27):5415-5425. 10.1182/blood-2008-10-182071, 2798860, 19797526.
25. Matsushita H, Nakajima H, Nakamura Y, Tsukamoto H, Tanaka Y, Jin G, Yabe M, Asai S, Ono R, Nosaka T, Sugita K, Morimoto A, Hayashi Y, Hotta T, Ando K, Miyachi H. C/EBPalpha and C/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene. Oncogene 2008, 27(53):6749-6760. 10.1038/onc.2008.285, 18776924.